Share your videos with the world

Sign Up | Log In | Help  

   
 
Related Tags: cancer  health  research  treatment  disease  2017  aacr  fda  multivu  8155051  childhood  cancer  tumor  health  research  hospital  st  jude  medical  overview  multivu  8121952  st  jude  children  research  hospital  medical  treatment  cancer  leukemia  illnesses  multivu  7924755  2016  breast  cancer  awareness  health  healthcare  prevention  treatment  research  multivu  7935851  st  jude  children  research  hospital  cancer  kids  health  therapy  treatment  technology  multivu  7713451  ohio  health  firefly  robotic  surgeons  robotics  surgery  medical  technology  surgical  lighting  tumor  removal  multivu  7342452  northwestern  mutual  disability  life  insurance  nmclientstory  family  income  financial  plan  security  multivu  7100754  del  mar  pharmaceutical  glioblastoma  brain  cancer  treatment  tumor  chemotherapy  healthcare  multivu  7037951  scripps  proton  therapy  health  radiation  therapy  tumors  treatment  patients  technology  multivu  65691  leukemia  cancer  childrens  hospital  philadelphia  chop  cell  therapy  immunotherapy  treatment  research  multivu  64394  elekta  versa  high  definition  radiation  therapy  cancer  treatments  agility  mlc  oncology  health  technology  multivu  60246  saint  jude  childrens  research  hospital  chilis  kids  cancer  multivu  57540 
Search // tumor
Results 1-11 of 11 for ' tumor ' (0 seconds)
Federally funded research that provides a deep understanding of cancer is spurring advances against many types of the disease. With a strong bipartisan commitment from Congress to keep investment in biomedical research a national priority, we can accelerate our pace of progress and save more lives from cancer, according to the seventh annual American Association for Cancer Research (AACR) Cancer Progress Report, released today. Basic research in the fields of immunology and cancer genetics has recently been harnessed to develop two new forms of cancer treatment: immunotherapy and precision medicine. As detailed in the report, the utility of these treatments is expanding rapidly. In May 2017, the U.S. Food and Drug Administration (FDA) heralded a new dawn for precision medicine when it approved the immunotherapeutic pembrolizumab (Keytruda) for treating patients with any solid tumor harboring specific genetic characteristics. This is the first anticancer therapeutic approved based on cancer biomarkers rather than the location in the body where the cancer originated. To view the multimedia release go to: https://www.multivu.com/players/English/8155051-aacr-cancer-progress-report-2017/
Categories // Miscellaneous 
Added: 89 days ago by MultiVuVideos
Runtime: 1m0s | Views: 7 | Comments: 0
Not yet rated
 

 

 

In an effort to improve outcomes for patients with some of the deadliest childhood cancers, St. Jude Children’s Research Hospital scientists have created the world’s largest collection of pediatric solid tumor samples, drug-sensitivity data and related information and have made the resource available at no charge to the global scientific community. St. Jude and the Howard Hughes Medical Institute collaborated to create the resource, known as the Childhood Solid Tumor Network. The work is reported today as an advance online publication in the scientific journal Nature. “Survival rates for children with recurrent solid tumors have not improved significantly in more than 20 years and remain below 30 percent,” said corresponding author Michael Dyer, Ph.D., chair of the St. Jude Department of Developmental Neurobiology and a Howard Hughes Medical Institute investigator. “This research will change that by promoting scientific collaboration to leverage the efforts of researchers worldwide to advance understanding and ultimately treatment of pediatric solid tumors.” To view the multimedia release go to: https://www.multivu.com/players/English/8121952-st-jude-childrens-childhood-solid-tumor-network/
Categories // Miscellaneous 
Added: 102 days ago by MultiVuVideos
Runtime: 1m34s | Views: 2 | Comments: 0
Not yet rated
 

 

 

Breast cancer now represents one in four of all cancers in women worldwide and touches lives every day. While experiences with the disease may vary, the desire to defeat breast cancer is universal. This year, in honor of a shared vision for a world without this disease, The Estée Lauder Companies’ Breast Cancer Awareness (BCA) Campaign celebrates the power of global solidarity by encouraging people around the world to “Take Action Together to Defeat Breast Cancer.” The 2016 BCA Campaign invites women, men and families to draw inspiration from one another and unite in action on BCAcampaign.com and social media, while supporting lifesaving breast cancer research. Over the past two decades, The Estée Lauder Companies’ BCA Campaign, launched by the late Evelyn H. Lauder, co-creator of the Pink Ribbon and founder of the Breast Cancer Research Foundation® (BCRF), has been a leading voice for breast cancer awareness around the world, igniting a global movement that has helped save millions of lives and fund innovative breast cancer research. Today, The BCA Campaign is active in more than 70 countries and has raised more than $65 million to support global research, education and medical services, with more than $50 million funding 200 BCRF medical research grants worldwide over the past 22 years. These funds help accelerate critical research across wide-ranging areas such as tumor biology, heredity and ethnicity, lifestyle and prevention, treatment, survivorship and metastasis. Around the world, The BCA Campaign partners with more than 60 breast cancer organizations focused on breast cancer research, education and medical services. This year, The BCA Campaign is committed to raising $6 million in support of its mission to defeat breast cancer through education and medical research. To view the multimedia release go to: http://www.multivu.com/players/English/7935851-estee-lauder-bca-campaign-2016/
Categories // Miscellaneous 
Added: 437 days ago by MultiVuVideos
Runtime: 0m30s | Views: 87 | Comments: 0
Not yet rated
 

 

 

A Firefly is lighting up operating rooms, making it easier for robotic surgeons to remove tumors. However, this Firefly is not the type that children catch in a jar during warm summer evenings. Instead, it’s a technology that uses a wavelength of light not visible to the human eye. A special dye is then injected which causes a bright green fluorescence of certain tissues, hence the name “Firefly.” This green glow lets surgeons clearly see the difference between cancerous and healthy tissue when performing surgery, allowing them to remove the tumor while saving the rest of the healthy organ. To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7342452-firefly-lighting-operating-rooms/
Categories // Miscellaneous 
Added: 998 days ago by MultiVuVideos
Runtime: 2m12s | Views: 228 | Comments: 0
Not yet rated
 

 

 

John Peden was one of those larger-than-life personalities. “When he would walk into a room, it was like all the attention was on him,” said his stepdaughter, Jenna Peden. “He just had this power emanating out of him.” The 6-foot, 4-inch former U.S. Air Force captain was a respected dental surgeon in Nashville. He was active in his church and made many mission trips to provide dental care in Central America through Health Talents International. That’s why it was such a shock to his family and friends when an MRI revealed a brain tumor the size of a golf ball. “Life as we knew it was no more,” said his wife, Vicki Peden. “John never worked another day in his life.” To view the Multimedia News Release, go to http://www.multivu.com/players/English/7100754-northwestern-mutual-client-stories-planning-preparation-pay-off/
Categories // People and Blog  Business 
Added: 1148 days ago by MultiVuVideos
Runtime: 3m7s | Views: 421 | Comments: 0
Not yet rated
 

 

 

Jeffrey Bacha, president and CEO of DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) (“DelMar Pharma” or “DelMar”) discusses new clinical research and treatments in development for glioblastoma, the most common and severe form of brain cancer. Less than one out of three patients will survive two years after their diagnosis. DelMar is a cancer-focused company developing new therapies for patients with little to no treatment options. To view the Multimedia News Release, go to: http://www.multivu.com/mnr/7037951-delmar-pharmaceuticals-glioblastoma-brain-tumor-awareness-month
Categories // Science and Technology 
Added: 1320 days ago by MultiVuVideos
Runtime: 6m10s | Views: 474 | Comments: 0
Not yet rated
 

 

 

During a live global event, Elekta announced the launch of Versa HD™, an advanced linear accelerator system designed to improve patient care and treat a broader spectrum of cancers. Featuring high precision beam shaping and tumor targeting, Versa HD also unveils new capabilities designed to maximize health care system resources and deliver highly sophisticated therapies without compromising treatment times. To view Multimedia News Release, go to http://www.multivu.com/mnr/60246-elekta-sets-new-benchmark-for-cancer-treatment-launch-of-versa-hd-system
Categories // Science and Technology 
Added: 1746 days ago by MultiVuVideos
Runtime: 3m15s | Views: 415 | Comments: 0
    
 

 

 

It was January 2012, Isaac dribbled the ball; shot it through the hoop, swish! This was a simple moment the 15-year-old athlete who once participated in cross country, soccer and basketball, thought he’d never experience again. Ten months earlier, Isaac was diagnosed with a brain tumor. He became a patient at St. Jude Children’s Research Hospital® and through extensive treatment and care, his cancer is in remission and he is able to play the sports he loves. Chili’s® Grill & Bar is helping St. Jude patients like Isaac enjoy their own special, everyday moments through the brand’s ninth annual Create-A-Pepper to Fight Childhood Cancer campaign. Participating Chili’s restaurants nationwide and in Puerto Rico are joining in the fight against childhood cancer and other life-threatening diseases. September is National Childhood Cancer Awareness month and through Sept. 26, Chili’s guests can help the cause by donating at their local restaurants and online. To view Multimedia News Release, go to http://www.multivu.com/mnr/57540-chili-s-create-a-pepper-for-st-jude
Categories // News and Politics 
Added: 1924 days ago by MultiVuVideos
Runtime: 0m31s | Views: 3119 | Comments: 0
Not yet rated
 

 

 

Researchers studying the genetic roots of the most common malignant childhood brain tumor have discovered missteps in three of the four subtypes of the cancer that involve genes already targeted for drug development.
Categories // Science and Technology 
Added: 2000 days ago by MultiVuVideos
Runtime: 3m2s | Views: 3842 | Comments: 0
Not yet rated
 

 

 

http://www.youtube.com/watch?v=yXMddEIdusg[EXTRACT] Dr. Samuel Aguiar Jr. - Hospital do Câncer - AC CamargoMédico do Departamento de Cirurgia Pélvicahttp://199.238.143.96/index.php?option=com_content&task=view&id=29&Itemid=33
Categories // Miscellaneous 
Added: 2100 days ago by johngeltkn
Runtime: 3m45s | Views: 5139 | Comments: 0
Not yet rated
 

 

 

New findings from the St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project (PCGP) have helped identify the mechanism that makes the childhood eye tumor retinoblastoma so aggressive. The discovery explains why the tumor develops so rapidly while other cancers can take years or even decades to form. The finding also led investigators to a new treatment target and possible therapy for the rare childhood tumor of the retina, the light-sensing tissue at the back of the eye. The study appears in the January 11 advance online edition of the scientific journal Nature. To view Multimedia News Release, go to http://www.multivu.com/mnr/46767-st-jude-genome-project-treatment-childhood-eye-tumor-retinoblastoma
Categories // News and Politics 
Added: 2153 days ago by MultiVuVideos
Runtime: 5m1s | Views: 3729 | Comments: 0
Not yet rated
 

 

 

Page 1 of 1  |  Go to page   



About Us   |   Help  |   Advertise on ClipMoon   |   Terms of Use   |   Privacy Policy   |   Copyright   |   Contact   |   Link us   |   RSS 
Copyright © 2007-2017 ClipMoon.com. All rights reserved.